The Poultry Site

Precision matters: tackling quality issues in on‑farm vaccination

Automation transforms vaccination into a traceable, well‑controlled operation that supports performance metrics.

ViiV’s four-monthly HIV drug maintains viral suppression at 12 months

ViiV Healthcare has reported several successful HIV trials at CROI 2026, including its investigational candidates lotivibart, VH184 and VH499.
Le Lézard

ViiV Healthcare presents pipeline data for two investigational HIV treatment therapies with potential for twice-yearly dosing

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders,* today announced data from its phase 1 study of long-acting formulations of VH184, ...